Mild cognitive impairment: not much harm; not much help by Jeremy D. Isaacs

Get full text

Alzheimer's disease: Have we opened the Golden Gate to disease-modifying therapy? by Jeremy D. Isaacs

Get full text

Non-hyperammonaemic valproate encephalopathy after 20 years of treatment by Elizabeth Caruana Galizia, Jeremy D. Isaacs, Hannah R. Cock

Get full text

PDE5 inhibitor drugs for use in dementia by Atticus H. Hainsworth, Ottavio Arancio, Fanny M. Elahi, Jeremy D. Isaacs, Feixiong Cheng

Get full text

The promise of molecular science in brain health. What breakthroughs are anticipated in the next 20 years? by Atticus H Hainsworth, Thomas P Blackburn, Elizabeth M Bradshaw, Fanny M Elahi, Philip B Gorelick, Jeremy D Isaacs, Anders Wallin, Steven CR Williams

Get full text

Quasi-diffusion magnetic resonance imaging (QDI): A fast, high b-value diffusion imaging technique by Thomas R. Barrick, Catherine A. Spilling, Carson Ingo, Jeremy Madigan, Jeremy D. Isaacs, Philip Rich, Timothy L. Jones, Richard L. Magin, Matt G. Hall, Franklyn A. Howe

Get full text

Perfusion by Arterial Spin labelling following Single dose Tadalafil In Small vessel disease (PASTIS): study protocol for a randomised controlled trial by Mathilde M. H. Pauls, Natasha Clarke, Sarah Trippier, Shai Betteridge, Franklyn A. Howe, Usman Khan, Christina Kruuse, Jeremy B. Madigan, Barry Moynihan, Anthony C. Pereira, Debbie Rolfe, Egill Rostrup, Caroline E. Haig, Thomas R. Barrick, Jeremy D. Isaacs, Atticus H. Hainsworth

Get full text

What does aducanumab treatment of Alzheimer's disease mean for research on vascular cognitive disorders? by Anders Wallin, Suvarna Alladi, Sandra E Black, Christopher Chen, Steven M Greenberg, Deborah Gustafson, Jeremy D Isaacs, Hanna Jokinen, Raj Kalaria, Vincent Mok, Leonardo Pantoni, Florence Pasquier, Gustavo C Roman, Gary A. Rosenberg, Reinhold Schmidt, Eric E Smith, Atticus H Hainsworth

Get full text

Correction to: The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer’s disease by Craig W. Ritchie, Tom C. Russ, Sube Banerjee, Bob Barber, Andrew Boaden, Nick C. Fox, Clive Holmes, Jeremy D. Isaacs, Ira Leroi, Simon Lovestone, Matt Norton, John O’Brien, Jim Pearson, Richard Perry, James Pickett, Adam D. Waldman, Wai Lup Wong, Martin N. Rossor, Alistair Burns

Get full text

The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer’s disease by Craig W. Ritchie, Tom C. Russ, Sube Banerjee, Bob Barber, Andrew Boaden, Nick C. Fox, Clive Holmes, Jeremy D. Isaacs, Ira Leroi, Simon Lovestone, Matt Norton, John O’Brien, Jim Pearson, Richard Perry, James Pickett, Adam D. Waldman, Wai Lup Wong, Martin N. Rossor, Alistair Burns

Get full text

Testing the cognitive effects of tadalafil. Neuropsychological secondary outcomes from the PASTIS trial by Mathilde MH Pauls, Jessica Fish, Lauren R Binnie, Philip Benjamin, Shai Betteridge, Brian Clarke, Mohani-Preet K Dhillon, Rita Ghatala, Fearghal AH Hainsworth, Franklyn A Howe, Usman Khan, Christina Kruuse, Jeremy B Madigan, Barry Moynihan, Bhavini Patel, Anthony C Pereira, Egill Rostrup, Anan BY Shtaya, Catherine A Spilling, Sarah Trippier, Rebecca Williams, Robin Young, Thomas R Barrick, Jeremy D Isaacs, Atticus H Hainsworth

Get full text